Diaz-Vivancos, et al., Free Radic
Cai W, Sakaguchi M, Kleinridders A, Gonzalez-Del Pino G, Dreyfuss JM, ONeill BT, et al
Before using Wegovy, talk with your doctor about your health history
The Triple Agonist Mechanism and Weight Loss Huberman described retatrutide as a triple agonist of the GLP-1, glucagon, and GIP receptors, and noted that it is sometimes referred to as "GLP-3." He made a striking claim about the weight loss data: "In a phase three clinical trial in humans, it caused up to one-third loss of body weight
Foundayo (Orforglipron): The New Oral Option Orforglipron's April 2026 approval is notable for several reasons
Further research is needed to better understand the interplay between the DA system, glutamatergic system, and other neurotransmitter systems to improve interventions for preventing and treating alcohol dependence